File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Mass and relative elution time profiling: Two-dimensional analysis of sphingolipids in Alzheimer's disease brains

TitleMass and relative elution time profiling: Two-dimensional analysis of sphingolipids in Alzheimer's disease brains
Authors
KeywordsGalactosylceramide
Sphingolipid
Ceramide
Alzheimer's disease
Cerebroside
Lipidomic analysis
Issue Date2011
Citation
Biochemical Journal, 2011, v. 438, n. 1, p. 165-175 How to Cite?
AbstractCurrent lipidomic profiling methods rely mainly on MS to identify unknown lipids within a complex sample. We describe a new approach, involving LCxMS/MS (liquid chromatographyxtandem MS) analysis of sphingolipids based on both mass and hydrophobicity, and use this method to characterize the SM (sphingomyelin), ceramide and GalCer (galactosylceramide) content of hippocampus from AD (Alzheimer's disease) and control subjects. Using a mathematical relationship we exclude the influence of sphingolipid mass on retention time, and generate two-dimensional plots that facilitate accurate visualization and characterization of the different ceramide moieties within a given sphingolipid class, because related molecules align horizontally or vertically on the plots. Major brain GalCer species that differ in mass by only 0.04 Da were easily differentiated on the basis of their hydrophobicity. The importance of our method's capacity to define all of the major GalCer species in the brain samples is illustrated by the novel observation that the proportion of GalCer with hydroxylated fatty acids increased approximately 2-fold in the hippocampus of AD patients, compared with age- and gender-matched controls. This suggests activation of fatty acid hydroxylase in AD. Our method greatly improves the clarity of data obtained in a lipid profiling experiment and can be expanded to other lipid classes. © The Authors Journal compilation © 2011 Biochemical Society.
Persistent Identifierhttp://hdl.handle.net/10722/250975
ISSN
2023 Impact Factor: 4.4
2023 SCImago Journal Rankings: 1.612
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHejazi, Leila-
dc.contributor.authorWong, Jason W H-
dc.contributor.authorCheng, Danni-
dc.contributor.authorProschogo, Nicholas-
dc.contributor.authorEbrahimi, Diako-
dc.contributor.authorGarner, Brett-
dc.contributor.authorDon, Anthony S.-
dc.date.accessioned2018-02-01T01:54:14Z-
dc.date.available2018-02-01T01:54:14Z-
dc.date.issued2011-
dc.identifier.citationBiochemical Journal, 2011, v. 438, n. 1, p. 165-175-
dc.identifier.issn0264-6021-
dc.identifier.urihttp://hdl.handle.net/10722/250975-
dc.description.abstractCurrent lipidomic profiling methods rely mainly on MS to identify unknown lipids within a complex sample. We describe a new approach, involving LCxMS/MS (liquid chromatographyxtandem MS) analysis of sphingolipids based on both mass and hydrophobicity, and use this method to characterize the SM (sphingomyelin), ceramide and GalCer (galactosylceramide) content of hippocampus from AD (Alzheimer's disease) and control subjects. Using a mathematical relationship we exclude the influence of sphingolipid mass on retention time, and generate two-dimensional plots that facilitate accurate visualization and characterization of the different ceramide moieties within a given sphingolipid class, because related molecules align horizontally or vertically on the plots. Major brain GalCer species that differ in mass by only 0.04 Da were easily differentiated on the basis of their hydrophobicity. The importance of our method's capacity to define all of the major GalCer species in the brain samples is illustrated by the novel observation that the proportion of GalCer with hydroxylated fatty acids increased approximately 2-fold in the hippocampus of AD patients, compared with age- and gender-matched controls. This suggests activation of fatty acid hydroxylase in AD. Our method greatly improves the clarity of data obtained in a lipid profiling experiment and can be expanded to other lipid classes. © The Authors Journal compilation © 2011 Biochemical Society.-
dc.languageeng-
dc.relation.ispartofBiochemical Journal-
dc.subjectGalactosylceramide-
dc.subjectSphingolipid-
dc.subjectCeramide-
dc.subjectAlzheimer's disease-
dc.subjectCerebroside-
dc.subjectLipidomic analysis-
dc.titleMass and relative elution time profiling: Two-dimensional analysis of sphingolipids in Alzheimer's disease brains-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1042/BJ20110566-
dc.identifier.pmid21639855-
dc.identifier.scopuseid_2-s2.0-79960798079-
dc.identifier.volume438-
dc.identifier.issue1-
dc.identifier.spage165-
dc.identifier.epage175-
dc.identifier.eissn1470-8728-
dc.identifier.isiWOS:000294083400017-
dc.identifier.issnl0264-6021-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats